FILM (5-fluorouracil, ifosfamide, leucovorin and mitomycin C), an alternative chemotherapy regimen suitable for the treatment of advanced breast cancer in the 'out-patient' setting

Cancer Chemotherapy and Pharmacology

Volumn 44, Issue SUPPL., 1999, Pages

  Davidson, N G P ^a   Davis, A S ^b   Woods, J ^a   Snooks, S ^a   Cheverton, P D ^b  

^a NORTH MIDDLESEX UNIVERSITY HOSPITAL   (United Kingdom)

^b ASTA Medica Ltd   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOROURACIL; FOLINIC ACID; IFOSFAMIDE; MITOMYCIN C; MESNA;

ADULT; ADVANCED CANCER; AGED; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CANCER REGRESSION; CANCER SURVIVAL; CLINICAL ARTICLE; CONFERENCE PAPER; DRUG TOLERABILITY; FATIGUE; FEMALE; HUMAN; NAUSEA; PRIORITY JOURNAL; VOMITING; ANEMIA; ARTICLE; BLOOD TRANSFUSION; CLINICAL PROTOCOL; CLINICAL TRIAL; INOPERABLE CANCER; MALE; METASTASIS; OUTPATIENT CARE; TREATMENT OUTCOME;

ADULT; AGED; AMBULATORY CARE; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; BREAST NEOPLASMS, MALE; FEMALE; FLUOROURACIL; HUMANS; IFOSFAMIDE; LEUCOVORIN; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MITOMYCIN; OUTPATIENT CLINICS, HOSPITAL; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0033849518     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002800051111     Document Type: Conference Paper

References (12)

1. Veronesi U, Goldhirsch A, Yarnold J (1996) Breast cancer. In: Peckam et al (eds) Oxford Textbook of Oncology. Oxford University Press, Oxford
2. Bonadonna G, Veronesi U, Brambilla C et al (1990) Primary chemotherapy to avoid mastectomy in tumours with diameters of three centimetres or more. J Natl Cancer Inst 82: 1539-1545
3. Meanwell CA, Blake AE, Kelly KA, Honigsberger L, Blackledge G (1986) Prediction of ifosfamide/mesna associated encephalopathy. Eur J Clin Oncol 22: 815-819
4. Lind MJ, McGowan AT, Hadfield JA, Thatcher N, Crowther D, Fox BW (1989) The effect of ifosfamide and its metabolites on intracellular glutathione levels in vitro and vivo. Biochem Pharmacol 38: 1835-1840
5. Hortobagyi GN (1992) Activity of ifosfamide in breast cancer. Semin Oncol 19 [Suppl 12]: 36-42
6. Ingle JN, Krook JE, Mailliard JA, Hartmann LC, Wieand HS (1995) Evaluation of ifosfamide plus mesna as first-line chemotherapy in women with metastatic breast cancer. Am J Clin Oncol 18: 498-501
7. De Lena M, Jirillo A, Brambilla C, Villa S (1980) Mitomycin C in breast cancer resistant to hormone therapy and conventional chemotherapy. Tumori 66: 481-487
8. Van Oosterom AT, Powles TJ, Hamersma E, Smith IE, Englesman A (1979) Phase II study of mitomycin C in refractory advanced breast cancer. A multicentre study. In: Mouridsen HT, Palsof T (eds) Breast cancer - experimental and clinical aspects. Proc 2nd EORTC Breast Cancer Conference, Copenhagen 1979. Pergamon Press, Copenhagen, pp 275-276
9. Anderson NR (1993) 5-fluorouracil: a reappraisal of the optimal delivery in advanced breast cancer. J Infus Chemotherapy 3: 111-118
10. Hanson RH, Quebbeman E, Beatty P et al (1987) Continuous 5-fluorouracil infusion in refractory carcinoma of the breast. Breast Cancer Res Treat 10: 145-149
11. Davidson P, Cheverton P, Davis AS, Campbell N (1998) Pilot study of FILM (5-fluorouracil, ifosfamide, leucovorin and mitomycin C): an alternative chemotherapy regimen in the treatment of advanced breast cancer. Breast 7: 114
12. Hayward JL, Carbone PP, Heuson JC, Kumaoka S, Segaloff A, Rubens RD (1977) Assessment of response to therapy in advanced breast cancer. Eur J Cancer 13: 89